Curating from trusted global sources…
Curated from trusted global sources, refined into briefing-grade analysis with executive summaries, insights, and bullet-point takeaways.
Why the US Commerce Department is funding physics-and-chemistry AI to replace foreign minerals, including PFAS-free processes.
The company moves forward on an FDA path for its Huntington’s gene therapy, months after a public data dispute.
The $22 billion tie-up adds scale and leverage, forcing rivals, boards, and platforms to rethink how streaming dollars flow.
For boards betting on AI power demand, “announced capacity” may be a mirage: delays, grid issues, and duplicative counting.
Sphere Entertainment plans advanced-tech upgrades so the 1976 cult classic looks right on a curved screen.
The BBC details 3-year savings, with up to 2,000 roles ending and cuts hitting News and Originals.
Kaspersky says Wallpaper Engine content let executables run, targeting Steam users via anime girl wallpaper downloads.
A $100 million financing expansion and an AWS-alum CEO signal a pivot toward AI infrastructure demand, changing how investors should watch.
CNBC says SpaceX’s shares surge following its IPO Friday, forcing investors to reprice what “space” and “AI” are worth.
Big IPO, bigger options debut: what it means for investors, risk teams, and anyone benchmarking market appetite.
SpaceX exercised its option for Cursor in an all-stock deal worth $60 billion, reshaping AI dealmaking expectations.
The valuation jump of $1T in a single day changes the reference point for risk capital and public-market comps.
